Fritz von Weizsacker
Overview
Explore the profile of Fritz von Weizsacker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
1302
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Allgaier H, Arnold C, Baumert T, Becker G, Geissler M, Hafkemeyer P, et al.
Dtsch Med Wochenschr
. 2018 Jan;
143(1):40-45.
PMID: 29316584
No abstract available.
2.
Sinn M, Bischoff S, Nehls O, Pelzer U, von Weizsacker F, Kubicka S, et al.
Onkologie
. 2012 Dec;
35(12):755-60.
PMID: 23207621
Background: The low incidence and the variable presentation complicate clinical investigations on biliary tract cancer. The results of Valle et al. in 2009 provided, for the first time, an evidence-based...
3.
Zellmer S, Schmidt-Heck W, Godoy P, Weng H, Meyer C, Lehmann T, et al.
Hepatology
. 2010 Oct;
52(6):2127-36.
PMID: 20979052
Unlabelled: The cellular basis of liver regeneration has been intensely investigated for many years. However, the mechanisms initiating hepatocyte "plasticity" and priming for proliferation are not yet fully clear. We...
4.
Walter D, Schmich K, Vogel S, Pick R, Kaufmann T, Hochmuth F, et al.
Hepatology
. 2008 Nov;
48(6):1942-53.
PMID: 19003879
Unlabelled: Fas/CD95-induced apoptosis of hepatocytes in vivo proceeds through the so-called type II pathway, requiring the proapoptotic BH3-only Bcl-2 family member Bid for mitochondrial death signaling. Consequently, Bid-deficient mice are...
5.
Petersen J, Dandri M, Mier W, Lutgehetmann M, Volz T, von Weizsacker F, et al.
Nat Biotechnol
. 2008 Feb;
26(3):335-41.
PMID: 18297057
360 million people are chronically infected with the human hepatitis B virus (HBV) and are consequently prone to develop liver cirrhosis and hepatocellular carcinoma. As approved therapeutic regimens-which modulate patients'...
6.
Gotschel F, Kern C, Lang S, Sparna T, Markmann C, Schwager J, et al.
Exp Cell Res
. 2008 Feb;
314(6):1351-66.
PMID: 18261723
Glycogen synthase kinase-3 (GSK-3) is known to modulate cell survival and apoptosis through multiple intracellular signaling pathways. However, its hepatoprotective function and its role in activation of NF-kappaB and anti-apoptotic...
7.
Baumert T, Rosler C, Malim M, von Weizsacker F
Hepatology
. 2007 Jul;
46(3):682-9.
PMID: 17625792
Unlabelled: APOBEC3G (A3G) and APOBEC3C (A3C), 2 members of the APOBEC family, are cellular cytidine deaminases displaying broad antiretroviral activity. A3G inhibits hepatitis B virus (HBV) production by interfering with...
8.
Baumert T, Thimme R, von Weizsacker F
World J Gastroenterol
. 2007 Jan;
13(1):82-90.
PMID: 17206757
Infection with hepatitis B virus (HBV) leads to a wide spectrum of clinical presentations ranging from an asymptomatic carrier state to self-limited acute or fulminant hepatitis to chronic hepatitis with...
9.
Bengsch B, Spangenberg H, Kersting N, Neumann-Haefelin C, Panther E, von Weizsacker F, et al.
J Virol
. 2006 Nov;
81(2):945-53.
PMID: 17079288
The differentiation and functional status of virus-specific CD8+ T cells is significantly influenced by specific and ongoing antigen recognition. Importantly, the expression profiles of the interleukin-7 receptor alpha chain (CD127)...
10.
Fang X, Zeisel M, Wilpert J, Gissler B, Thimme R, Kreutz C, et al.
Hepatology
. 2006 May;
43(6):1326-36.
PMID: 16729312
Initiation of hepatitis C virus (HCV) infection is mediated by docking of the viral envelope to the hepatocyte cell surface membrane followed by entry of the virus into the host...